BP’s Clovis Oncology, Inc. CLVS Stock Holding History

BP’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,318	Closed	-$1.68M	–	301
2015 Q3	$1.68M	Buy	18,318 +14,135	+338%	+$1.22M	0.08%	250
2015 Q2	$368K	Buy	+4,183	New	+$358K	0.01%	273

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BP's CLVS Position: Q4 2015 in Review

BP sold out of Clovis Oncology, Inc. (CLVS) in Q4 2015, closing a stake of 18,318 shares — an estimated $1.68M sold.

BP first reported a position in CLVS in Q2 2015 and held it in 2 quarters. The position peaked at $1.68M in Q3 2015. 157 funds tracked by Wall St. Rank hold CLVS as of Q4 2015.

BP reported no remaining Clovis Oncology, Inc. position as of Q4 2015 after selling out during the quarter.
BP sold 18,318 Clovis Oncology, Inc. shares in Q4 2015, an estimated $1.68M.
BP first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 2 quarters.
BP's Clovis Oncology, Inc. position peaked at $1.68M in Q3 2015.
157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2015.

Based on BP's 13F filing for Q4 2015, filed 9 Feb 2016.